Literature DB >> 20556843

CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.

Guo-Wu Zhou1, Jia Hu, Qiang Li.   

Abstract

AIM: To clarify the association between CYP2E1 PstI/RsaI polymorphism and susceptibility to colorectal cancer.
METHODS: A meta-analysis based on 10 eligible case-control studies involving 4979 cases and 6012 controls was carried out to summarize the data on the association between CYP2E1 RsaI/PstI polymorphism and colorectal cancer risk.
RESULTS: In comparison of the homozygote c2c2 and c2 carriers (c1c2 + c2c2) and the homozygous wild-type genotype (c1c1), no association was found between CYP2E1 RsaI/PstI polymorphism and colorectal cancer risk [odds ratio (OR) = 1.24 (95% CI: 0.93-1.66) for c2c2; OR = 1.02 (95% CI: 0.88-1.19) for c2 carriers]. In stratified analysis, Caucasians with c2c2 homozygote appeared to have an increased risk of colorectal cancer (OR = 2.67, 95% CI: 1.03-6.89, P = 0.043), no significant associations were found in other groups.
CONCLUSION: c2c2 homozygote of CYP2E1 PstI/RsaI polymorphism may be associated with the increased risk of colorectal cancer in Caucasians, which needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556843      PMCID: PMC2887593          DOI: 10.3748/wjg.v16.i23.2949

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

Review 1.  Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.

Authors:  Edyta Reszka; Wojciech Wasowicz; Jolanta Gromadzinska
Journal:  Br J Nutr       Date:  2006-10       Impact factor: 3.718

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk.

Authors:  Loïc Le Marchand; Timothy Donlon; Ann Seifried; Lynne R Wilkens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

4.  Endogenous N-nitroso compounds, and their precursors, present in bacon, do not initiate or promote aberrant crypt foci in the colon of rats.

Authors:  G Parnaud; B Pignatelli; G Peiffer; S Taché; D E Corpet
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

5.  Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes.

Authors:  I Kiss; J Sándor; G Pajkos; B Bogner; G Hegedüs; I Ember
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

6.  CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.

Authors:  Chang-Ming Gao; Toshiro Takezaki; Jian-Zhong Wu; Min-Bin Chen; Yan-Ting Liu; Jian-Hua Ding; Haruhiko Sugimura; Jia Cao; Nobuyuki Hamajima; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

Review 7.  Cytochrome P450 gene polymorphism and cancer.

Authors:  Jose A G Agundez
Journal:  Curr Drug Metab       Date:  2004-06       Impact factor: 3.731

8.  [Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study].

Authors:  Wei-ping Yu; Kun Chen; Xin-yuan Ma; Kai-yan Yao; Qin-ting Jiang; Yan Zou; Hai-guang Zhou
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2004-05

9.  Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.

Authors:  Makiko Morita; Loïc Le Marchand; Suminori Kono; Guang Yin; Kengo Toyomura; Jun Nagano; Tetsuya Mizoue; Ryuichi Mibu; Masao Tanaka; Yoshihiro Kakeji; Yoshihiko Maehara; Takeshi Okamura; Koji Ikejiri; Kitaroh Futami; Takafumi Maekawa; Yohichi Yasunami; Kenji Takenaka; Hitoshi Ichimiya; Nobutoshi Imaizumi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.

Authors:  István Kiss; Zsuzsa Orsós; Katalin Gombos; Barna Bogner; András Csejtei; Antal Tibold; Zsuzsa Varga; Emese Pázsit; Ingrid Magda; Annamária Zölyomi; István Ember
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

View more
  11 in total

1.  Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Wei Liu; Fang Tian; Liping Dai; Yurong Chai
Journal:  Mol Biol Rep       Date:  2014-09-04       Impact factor: 2.316

Review 2.  Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir.

Authors:  Aga Syed Sameer
Journal:  Tumour Biol       Date:  2013-02-17

Review 3.  CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis.

Authors:  Ou Jiang; Rongxing Zhou; Daoquan Wu; Yu Liu; Wenjian Wu; Nansheng Cheng
Journal:  Tumour Biol       Date:  2013-01-25

4.  Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

Authors:  You-Cheng Lin; Xun Wu; Xue-Qiong Zhou; Rui Ren; Ze-Xuan Su; Chun-Xiao Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.

Authors:  Lei Cao; Jia Lin; Bing He; Hongge Wang; Juan Rao; Yingwen Liu; Xuemei Zhang
Journal:  Tumour Biol       Date:  2013-08-11

6.  Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population.

Authors:  A Syed Sameer; Saniya Nissar; Qurteeba Qadri; Shafia Alam; Shahid Mudasir Baba; Mushtaq A Siddiqi
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

7.  CYP1A1, CYP2E1 and EPHX1 polymorphisms in sporadic colorectal neoplasms.

Authors:  Glaucia Maria M Fernandes; Anelise Russo; Marcela Alcântara Proença; Nathalia Fernanda Gazola; Gabriela Helena Rodrigues; Patrícia Matos Biselli-Chicote; Ana Elizabete Silva; João Gomes Netinho; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

8.  CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.

Authors:  Chibo Liu; Haibao Wang; Chunqin Pan; Jianmin Shen; Yong Liang
Journal:  Tumour Biol       Date:  2012-01-17

9.  Colorectal cancer: molecular mutations and polymorphisms.

Authors:  Aga Syed Sameer
Journal:  Front Oncol       Date:  2013-05-13       Impact factor: 6.244

10.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.